Video Experimental Relacionado
Updated: Feb 25, 2026
07:51
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
12.8K
Especificidad, sinergia y antagonismo de fármacos en formulaciones basadas en poli (oxazolina) / poli (oxazina) de
Michael M Lübtow1, Lukas Hahn1, Malik Salman Haider1
1Functional Polymer Materials, Chair for Chemical Technology of Material Synthesis and the Bavarian Polymer Institute, University of Würzburg , Röntgenring 11, 97070 Würzburg, Germany.
Journal of the American Chemical Society
|July 28, 2017
Resumen
Las micelas de polímero se pueden ajustar con precisión para la administración de fármacos y la catálisis. Los cambios estructurales sutiles en las polioxazolinas y polioxazinas alteran significativamente la solubilización del fármaco, revelando interacciones específicas entre huésped y huésped.
Área de la Ciencia:
- Química de los polímeros
- Ciencias de los materiales
- Nanotecnología
Sus antecedentes:
- Las micelas de polímero crean entornos nanoscópicos únicos para diversas aplicaciones.
- El ajuste fino de la estructura anfífila permite un control preciso sobre el microambiente de la micela.
- Las propiedades hidrofílicas e hidrofóbicas son clave pero insuficientes para una caracterización detallada.
Objetivo del estudio:
- Investigar la capacidad de solubilización de las polioxazolinas y polioxazinas estructuralmente similares.
- Evaluar la interacción con dos fármacos insolubles en agua: la curcumina y el paclitaxel.
- Comprender el impacto de las modificaciones estructurales sutiles en las interacciones huésped-huésped dentro de las micelas poliméricas.
Principales métodos:
- Síntesis de una pequeña biblioteca de polioxazolinas y polioxazinas estructuralmente similares.
- Evaluación de la capacidad de solubilización de la curcumina y el paclitaxel.
- Análisis de los efectos sinérgicos y antagónicos en la coformulación.
Principales resultados:
- Se observaron especificidades significativas y ortogonales en la solubilización del fármaco, incluso con intercambios de un solo grupo metileno.
- Surgieron patrones de solubilización sinérgicos y antagónicos profundos para los fármacos coformulados.
- Se han demostrado especificidades pronunciadas de huésped en micelas de polímero.
Conclusiones:
- Los cambios estructurales sutiles en los anfífilos poliméricos conducen a interacciones huésped-huésped significativas y específicas.
- El ajuste del microambiente de las micelas poliméricas es crucial para optimizar la administración de fármacos y la catálisis micelar.
- Los hallazgos avanzan en la comprensión de la química huésped-huésped en sistemas nanoscópicos.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:14Agonism and Antagonism: Quantification
1.2K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.2K
01:30Combined Effects of Drugs: Antagonism
11.9K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.9K
01:21Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
788
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
788
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
57
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
57
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
208
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
208
01:25Dose-Response Relationship: Selectivity and Specificity
10.1K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.1K